Press releases

Sanner Group opens second state-of-the-art manufacturing facility in China

Expansion reflects growing demand for the company’s high-quality pharma and medtech products.


Sanner Envelope
[Translate to Français:]

[Translate to Français:]

Sanner Group opens second state-of-the-art manufacturing facility in China

Expansion reflects growing demand for the company’s high-quality pharma and medtech products.


September 14, 2023 – The Sanner Group, a global leader in the development and production of active healthcare packaging and medical device components, is expanding production capacity in the Asia-Pacific region, bringing a new manufacturing facility on stream in Kunshan, China.


Kunshan II will operate alongside Sanner’s existing manufacturing facility, increasing flexibility and boosting production capacity by 80%. A key element of the company’s broader expansion plans, the new facility will create sufficient capacity to meet demand across the region for Sanner’s intelligent, innovative, high quality pharmaceutical and medical technology products. The investment reflects Sanner’s commitment to customers in Asia, cementing its position as a leading contract development and manufacturing organization (CDMO).


“Sanner China is a trusted market leader in Asia-Pacific with designated high-tech[1] status,” said Ralf Tiemann, Sanner CEO Asia-Pacific. “The new facility marks an important milestone in the successful 23-year history of Sanner China and will substantially enhance our offering to customers in this vital region. With Kunshan II onstream we’ll be able to reliably meet growing demand, providing all our customers with products of outstanding quality backed by exceptional service.”


Kunshan II is excellent news for the growing number of customers that rely on Sanner for medical device manufacture and supports significant growth of the company as the region’s main supplier of desiccant based test strip packaging, and other primary packaging solutions. Offering thousands of square meters of accessible production space, it is ultra-modern and equipped with the latest cutting-edge technology and facilities for manufacture to the very highest quality standards.


The new 18,000 m2 facility includes:

  • Over 4,000 m2 of production space, all classified to Class D clean room standard for the GMP-compliant production of drug delivery devices and pharmaceutical and medical packaging products,
  • Highly efficient energy-saving injection molding machines,
  • Modern warehouse, workshop, and office areas,
  • Space for further expansion.


The construction and commissioning of Kunshan II is just one element of Sanner’s ambitious growth plans which will see developments in Asia Pacific echoed by expansion in Germany. A new production facility and headquarters planned for the company’s Bensheim site is scheduled to come onstream in September 2024, to more than double current production capacity in Germany.



About Sanner

Sanner GmbH was founded in 1894. Headquartered in Germany and leveraging its best-in-class manufacturing facilities across Germany, France, Hungary, and China. Sanner has successively developed from a global market leader for desiccant closures and effervescent tablet packaging into a sought-after provider of customized solutions in the areas of medical devices and diagnostics, pharmaceuticals, and consumer healthcare. Today, Sanner supplies its products to more than 150 countries globally and has over 600 employees. In November 2021, Sanner received a majority investment from GHO Capital, a leading specialist healthcare investor. Together, GHO and the fourth generation of the Sanner family will continue to drive growth in the business, creating intelligent healthcare solutions for a better quality of life.